LRRk2 mutations result in impaired mitochondrial function, disrupt mitophagy, and increase the susceptibility of dopaminergic neurons to PD-inducing reagents, including MPP+, 6-OHDA, and ROSs [183]. This evidence concerns the gene LRRK2 and Parkinson disease.